Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignanciesDidier Blaise, Anne-Marie Stoppa, Sabine Fürst et al.|Experimental Hematology|2010Cited by 39
List of ContributorsMufti Naeem Ahmad, Elizabeth J. Shpall, Sairah Ahmed et al.|Elsevier eBooks|2019Cited by 0